56
In band
Moving averages
SMA 200$6.37+10.83%
Company profile
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
SectorHealthcare
IndustryBiotechnology
Market cap$168.37M
P/E ratioNone
EPS$-1.26
Beta1.275
Dividend yield0.00%
52-week high$9.62
52-week low$3.53
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
CHRS
Coherus Biosciences Inc
RSI 34
IVVD
Invivyd Inc
RSI 37
NERV
Minerva Neurosciences Inc
RSI 32
TRDA
Entrada Therapeutics Inc
RSI 41
SAVA
Cassava Sciences Inc
IMUX
Immunic Inc
RSI 40
RSI alerts for DTIL
An email when DTIL closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 15 October 2026 at 1:18 AM EDT